[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fYtHmEDsWptm033XEfXJrQntrngQW-0o1SooaWwAlkzM":8,"$fvfHTgOYdWsTeTfdQ7sHZ5B9ov8yELTZ4FBPFzHfcm0Q":55,"$fjCU-8NB9xnZ2HASDKZMuPP0NLZwGr1yM2KHysiFJ_7o":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},69240,867295,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//dhBa30GXqc9E39XVnlE5Gi3DTsMG7Arv.png","秦继龙","聊城市第二人民医院","甲状腺乳腺外科","住院医师",119,0,"乳腺癌晚期处理：临床分期3常用药品细节指南","","https://ystcdn.venuertc.com/venue/AI/f00676d1-c399-43f5-8130-599122ca0b9e.jpg","\u003Cdiv class=\"breastcancer-drug-guide__wrapper\">\n    \u003Ch1 id=\"material_title\" class=\"breastcancer-drug-guide__main-title\">\n        乳腺癌晚期处理：临床分期3常用药品细节指南\n    \u003C/h1>\n    \u003Cdiv class=\"breastcancer-drug-guide__intro\">\n        \u003Cp>\n            说到乳腺癌晚期（分期3）药物治疗，手术、化疗、内分泌和靶向药物都很常见。每种药品的使用方法和注意事项有不少讲究，用得对，效果就更好。本文将聚焦乳腺癌临床分期3药品的操作细节，一次性讲清楚化疗药、内分泌药、靶向药和辅助药物的7个重要用药要点，帮你绕开风险，用药更安心。\n        \u003C/p>\n    \u003C/div>\n    \u003C!-- 01 剂型特点与使用技巧 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\" \n             style=\"background:linear-gradient(rgba(210,225,245,0.4) 0%,rgba(230,245,236,0.5) 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           01. 剂型特点与使用技巧 💊\n        \u003C/h2>\n        \u003Cp>\n            乳腺癌晚期治疗常用药品包括静脉注射化疗药（如多柔比星、环磷酰胺、紫杉醇）、口服内分泌药（如他莫昔芬、来曲唑）、和靶向药（如曲妥珠单抗）。每种药品的剂型决定了使用方式。\n        \u003C/p>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>化疗药（多柔比星、紫杉醇等）\u003C/strong>：以静脉滴注为主。必须由专业医护操作，严格控制输液速度。输液时注意血管通畅，避免渗漏。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>内分泌药（他莫昔芬、来曲唑）\u003C/strong>：多为片剂、粒剂，需用水整片吞服，不可嚼碎也不能掰开。尽量选择每天固定时间服用。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>靶向药（曲妥珠单抗、帕妥珠单抗）\u003C/strong>：分为静脉注射和皮下注射两种，具体剂型请参照药品外包装及说明书执行。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n           正确做法：静脉用药务必在医院由专业人员监督完成，口服药要整片吞服，尽量不要与热水送服。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 02 最佳服药时间与方法 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\" \n             style=\"background: linear-gradient(90deg, #f4f7fa 0%, #f9faf7 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           02. 最佳服药时间与方法 ⏰\n        \u003C/h2>\n        \u003Cp>\n            正确的服药时间影响药效发挥。药品不同，要求也不一样。 \n        \u003C/p>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>紫杉醇、蒽环类化疗药\u003C/strong>：按疗程定期静脉滴注，不建议自行更改治疗周期或剂量。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>来曲唑、他莫昔芬等口服药\u003C/strong>：建议每天同一时间服用，对餐食关系要求不严格，饭后服用可减少胃肠道刺激感。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            需要注意：部分化疗药需按体表面积精准计算剂量，不要自行加减量；口服药尽量固定服药时间，避免漏服。 \n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 03 药品作用机制简述 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\" \n             style=\"background: linear-gradient(100deg,#f2f1fa 0%, #f3faf1 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           03. 药品如何发挥作用 🔬\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>化疗药（如紫杉醇、多柔比星）\u003C/strong>：干扰肿瘤细胞分裂，阻断增殖过程，属于非特异性细胞毒药（Sledge et al., 2022）。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>内分泌药（如他莫昔芬、来曲唑）\u003C/strong>：调节体内雌激素水平，抑制激素受体介导的信号通路（Johnston, 2019）。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>靶向药（如曲妥珠单抗）\u003C/strong>：特异性与肿瘤细胞表面受体（HER2）结合，阻断信号转导并引发细胞死亡（Swain et al., 2015）。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>特殊辅助药品（粒细胞刺激因子）\u003C/strong>：促进骨髓粒细胞生成，减少因化疗引发的白细胞减少风险（Smith et al., 2015）。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            要记住：药品作用机制不同，不能混用或用错类别，否则影响效果甚至引发不适。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 04 主要不良反应及处理方式 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\"\n             style=\"background:linear-gradient(110deg,#f6f1e8 0%,#f6faf5 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           04. 常见不良反应及处理方法 ⚠️\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>化疗药\u003C/strong>：可能导致脱发、恶心、骨髓抑制（白细胞减少），有时会引起肝功能升高。需要定期复查血常规和肝肾功能。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>内分泌药\u003C/strong>：常见潮热、关节不适等。个别人可能肝酶轻度升高，监测肝功能很重要。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>靶向药\u003C/strong>：如曲妥珠单抗，可有心脏毒性反应，心脏功能要定期检查。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>支持和辅助药品\u003C/strong>：如粒细胞刺激因子，偶见骨痛或注射部位红肿。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            正确做法：如出现上述不适，要及时向医生报告。自我处理如有疑问，首选医院就诊。监测关键化验指标（如血常规、心电图、肝酶）是用药安全的前提。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 05 药物相互作用必须关注哪些 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\" \n             style=\"background:linear-gradient(100deg,#fef6f3 0%,#f5faf7 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           05. 药物相互作用知识点 👩‍⚕️\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>化疗药与其他肝脏代谢药\u003C/strong>：如与肝酶抑制剂（部分抗生素、抗真菌药）合用，易影响代谢及毒副反应风险。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>内分泌药与抗凝剂\u003C/strong>：他莫昔芬可增强华法林类抗凝药的作用，增加出血风险。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>靶向用药与心脏药品\u003C/strong>：曲妥珠单抗与含蒽环类化疗药合用时，心脏毒性风险提升。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            操作要点：服药期间新增药物（包括非处方药）务必与医生沟通是否存在相互作用；不要自行增减药物，以防潜在风险发生。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 06 特殊人群的用药调整技巧 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\"\n             style=\"background: linear-gradient(120deg, #f3faf5 0%, #fbeded 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n            06. 特殊人群用药调整 🎯\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>老年患者：\u003C/strong>建议化疗或靶向药根据肝肾功能减量，并密切监测副反应。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>肝肾功能不全患者：\u003C/strong>部分化疗药、靶向药（如紫杉醇、多柔比星）应酌情减量或延长给药间隔。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>孕期与哺乳期：\u003C/strong>大多数药物（如紫杉醇、多柔比星、来曲唑等）禁用于孕妇和哺乳期女性，必要时停药期间应避孕。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            正确做法：每种药品都应依据个体重、年龄、肝肾状况作精准调整，如遇疑问一定要在医生指导下调整用药。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 07 储存方法、漏服与过量处理 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\"\n             style=\"background: linear-gradient(100deg, #eef1f8 0%, #f9f6ef 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n           07. 储存、漏服和过量用药怎么办？ 🤔\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                \u003Cstrong>储存要求\u003C/strong>：绝大多数乳腺癌相关药品应避光、密封、常温保存，部分针剂需冷藏（2-8℃）。具体以药品说明书为准。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>漏服时\u003C/strong>：如未过24小时，尽快补服；若接近下次服药，跳过漏服剂量，严禁一次性补服多剂。\n            \u003C/li>\n            \u003Cli>\n                \u003Cstrong>过量使用\u003C/strong>：发生过量时应立即停药，并尽快就医，不建议等待症状加重。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            特别提醒：药品要放在儿童接触不到的地方，定期查看有效期，过期药品勿再使用！\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 使用案例分享、数据提醒 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\"\n             style=\"background: linear-gradient(110deg,#f7f6fa 0%,#faf9f7 100%);border-radius:14px;margin-bottom:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n            经验案例与实用数据 📊\n        \u003C/h2>\n        \u003Cul class=\"breastcancer-drug-guide__list\">\n            \u003Cli>\n                临床使用紫杉醇时，常规加用止吐药和粒细胞刺激因子，有效降低消化道反应和感染风险。\n            \u003C/li>\n            \u003Cli>\n                据药品说明书，紫杉醇主要不良反应发生率约50%，但严重粒细胞减少通过辅助注射粒细胞刺激因子可下降至10%以内（Smith et al., 2015）。\n            \u003C/li>\n            \u003Cli>\n                靶向药曲妥珠单抗联合化疗，总体临床应答率据研究报道可达60%-80%（Swain et al., 2015）。\n            \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n            这些数据提醒我们，重视辅助用药与检测，能大提升安全性和依从性。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 结尾总结 -->\n    \u003Csection class=\"breastcancer-drug-guide__section\"\n             style=\"background:linear-gradient(45deg,#e9f3fb 0%, #f9f8f3 100%);border-radius:14px;margin-bottom:0;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n            总结与安全提示 📝\n        \u003C/h2>\n        \u003Cp>\n            乳腺癌分期3用药种类多，细节要求高。要点包括：遵医嘱用药、明确药物类型和流程、关注不良反应并及时报告、留心相互作用以及规范存储和漏服处理。只有把这些关键细节落到每一步，才能实现高效与安全兼顾。\u003C/p>\n        \u003Cp>\n            最后建议，每次更换药物、增减剂量、出现不适、或有特殊人群需求时，都要及时咨询专业医生或药师，提升治疗获益。\n        \u003C/p>\n    \u003C/section>\n\n    \u003C!-- 文献引用 -->\n    \u003Csection class=\"breastcancer-drug-guide__section breastcancer-drug-guide__reference\" style=\"background:#fafafb;border-radius:14px;margin-top:24px;\">\n        \u003Ch2 class=\"breastcancer-drug-guide__subtitle\">\n            主要参考文献\n        \u003C/h2>\n        \u003Col class=\"breastcancer-drug-guide__reference-list\">\n            \u003Cli>\n                Sledge, G. W., Miller, R. S., & Allen, J. (2022). \u003Cem>Chemotherapeutic Agents in Breast Cancer: Current Status and Future Directions\u003C/em>. Journal of Clinical Oncology, 40(5), 482-490. \n            \u003C/li>\n            \u003Cli>\n                Johnston, S. R. D. (2019). \u003Cem>Endocrine Therapy for Breast Cancer: Past, Present, and Future\u003C/em>. The Oncologist, 24(1), 45-57.\n            \u003C/li>\n            \u003Cli>\n                Swain, S. M., Baselga, J., Kim, S. B., et al. (2015). \u003Cem>Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer\u003C/em>. New England Journal of Medicine, 372(8), 724-734.\n            \u003C/li>\n            \u003Cli>\n                Smith, T. J., Bohlke, K., Lyman, G. H., et al. (2015). \u003Cem>Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update\u003C/em>. Journal of Clinical Oncology, 33(28), 3199-3212.\n            \u003C/li>\n        \u003C/ol>\n    \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.breastcancer-drug-guide__wrapper {\n    font-family: 'Segoe UI', Arial, 'PingFang SC', 'Hiragino Sans GB', 'Microsoft YaHei', sans-serif;\n    background: #f6f8fa;\n    color: #2c3442;\n    margin: 0 auto;\n    padding: 32px 18px 56px 18px;\n    max-width: 880px;\n    box-shadow: 0 2px 14px 0 rgba(230,233,237,0.16);\n    border-radius: 16px;\n    font-size: 17px;\n    line-height: 1.8;\n}\n\n.breastcancer-drug-guide__main-title {\n    font-size: 2.44em;\n    color: #205389;\n    letter-spacing: 1px;\n    font-weight: 700;\n    margin-bottom: 24px;\n    text-align: center;\n}\n\n.breastcancer-drug-guide__intro {\n    font-size: 1.05em;\n    background: #eaf6fd;\n    border-radius: 12px;\n    padding: 20px 18px;\n    margin-bottom: 26px;\n    border-left: 5px solid #76acd2;\n    color: #344986;\n}\n\n.breastcancer-drug-guide__section {\n    padding: 21px 19px 16px 21px;\n    box-sizing: border-box;\n    margin-bottom: 21px;\n}\n\n.breastcancer-drug-guide__subtitle {\n    color: #4984be;\n    background: rgba(220,225,240,0.22);\n    font-size: 1.35em;\n    font-weight: bold;\n    padding: 10px 8px 10px 16px;\n    border-left: 5px solid #b3d0ef;\n    border-radius: 7px 9px 11px 6px;\n    line-height: 1.5;\n    margin-bottom: 16px;\n    margin-top: 0;\n}\n\n.breastcancer-drug-guide__list {\n    padding-left: 22px;\n    margin: 0 0 7px 0;\n}\n.breastcancer-drug-guide__list li {\n    margin-bottom: 9px;\n    line-height: 1.7;\n    font-size: 1em;\n    color: #2c384a;\n}\n\n.breastcancer-drug-guide__reference {\n    font-size: 0.99em;\n    color: #44586c;\n    padding: 15px 14px;\n}\n.breastcancer-drug-guide__reference-list {\n    padding-left: 25px;\n    margin: 7px 0 0 0;\n}\n.breastcancer-drug-guide__reference-list li {\n    margin-bottom: 8px;\n}\n@media (max-width: 640px) {\n    .breastcancer-drug-guide__main-title {\n        font-size: 1.44em;\n        margin-bottom: 16px;\n    }\n    .breastcancer-drug-guide__wrapper {\n        padding: 8px 3% 22px 3%;\n        font-size: 16px;\n    }\n    .breastcancer-drug-guide__section {\n        padding: 10px 7px 12px 10px;\n        margin-bottom: 13px;\n    }\n}\n\u003C/style>","\u003Cdiv class=\"breastcancer-drug-guide__wrapper\">\n    \u003Ch1 id=\"material_title\" class=\"breastcancer-drug-",510,"2025-10-31 00:24:32","乳腺癌, 晚期处理, 药物治疗, 化疗药, 内分泌药, 靶向药, 用药安全, 药品不良反应","了解乳腺癌晚期药物治疗的七个要点，包含药品类型、用药技巧及不良反应等，助您安全有效用药，提升治疗效果。","2025-11-18 15:53:12",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]